Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 06 Jan 2025

A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer

in Drugs Outcomes Research and Policies

Jie Fu
Yi-Dan Yan
Xu Wan
Xiao-Fan Sun
Xiu-Mei Ma
Ying-Jie Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516735

1,877 views

Systematic Review

Published on 06 Jan 2025

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Shipeng Zhang
Tianyi Dong
Jiawen Xian
Xinyue Xiao
Jiaqing Yuan
Tong Zeng
Kuan Deng
Rui Fu
Hanyu Wang
Yanjie Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519522

1,345 views

Review

Published on 06 Jan 2025

Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis

in Drugs Outcomes Research and Policies

Zhao Ren
Chunxing Li
Xin Zhang
Lichaoyue Sun
Hui Zhu
Dongxiao Wang
Yumin Wang
Shuo Liang
Guanchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484130

1,175 views

Review

Published on 03 Jan 2025

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review

in Drugs Outcomes Research and Policies

Chao Wang
Yunzhuo Dong
Peng Men
Ruixia Zhang
Ying Xiao
Yishan Bu
Yinpeng Qin
Xinran Zhang
Qianqian Dou
Yiheng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426772

1,968 views

Review

Published on 24 Dec 2024

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Junhui Qian
Jinlong Wan
Qin Yao
Yin Chen
Tao Ling
Yuejuan Zhang
Zhihua Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457226

1,564 views

Original Research

Published on 23 Dec 2024

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

in Drugs Outcomes Research and Policies

Przemyslaw Kardas
Bryan Bennett
Bijan Borah
Michel Burnier
Christopher Daly
Mickael Hiligsmann
Enrica Menditto
Andrew M. Peterson
Julia F. Slejko
Krisztina Tóth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444012

6,500 views
1 citation

Original Research

Published on 20 Dec 2024

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

in Drugs Outcomes Research and Policies

Zuojuan Xiang
Ling Ma
Zhengxiong Li
Yingzhou Fu
Yong Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488645

1,685 views

Systematic Review

Published on 19 Dec 2024

Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review

in Drugs Outcomes Research and Policies

Ruochen Qu
Yan Liu
Yan Zhao
Ziyi Wang
Shizhao Yuan
Shuai Liu
Jing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450120

1,172 views

Systematic Review

Published on 18 Dec 2024

Literature review analysis of aortitis induced by granulocyte-colony stimulating factor

in Drugs Outcomes Research and Policies

Ting Zhao
Huanhuan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487501

1,185 views

Original Research

Published on 18 Dec 2024

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

in Drugs Outcomes Research and Policies

Martin Wawruch
Miriam Petrova
Denisa Celovska
Sofa D. Alfian
Tomas Tesar
Jan Murin
Michal Trnka
Tomas Paduch
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464689

881 views

Perspective

Published on 17 Dec 2024

Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem

in Drugs Outcomes Research and Policies

Jonathan Hare
Morten Nielsen
Agnes Kiragga
Daniel Ochiel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499079

1,597 views
2 citations

Original Research

Published on 12 Dec 2024

Association between anthropometric indices and hypertension: identifying optimal cutoff points for U.S. adults across different populations

in Drugs Outcomes Research and Policies

Xueliang Zhang
Yan Nie
Dan Li
Chunhua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503059

1,905 views

Original Research

Published on 10 Dec 2024

Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa

in Drugs Outcomes Research and Policies

Jia Liang
Xueping Wu
Lu Chen
Lujia Feng
Xiangqing Hei
Yingying Diao
Yuke Ji
Huiyan Zheng
Zhenhua Zou
Dong Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477889

1,252 views

Perspective

Published on 10 Dec 2024

Reframing risks in rare diseases: economics of networks, spillovers, and scale

in Drugs Outcomes Research and Policies

Carlisle Ford Runge
James Campbell
Carlisle P. Runge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516725

686 views

Original Research

Published on 06 Dec 2024

Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia

in Drugs Outcomes Research and Policies

Jieun Jang
Hyun Jung Oh
Eui-Kyung Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488452

760 views

Original Research

Published on 03 Dec 2024

Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

in Drugs Outcomes Research and Policies

Xiang Xiao
Shuming Ji
Tao Zheng
Tianzhu Wang
Dapeng Jiang
Fang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468435

1,338 views